These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28318883)

  • 1. Predicting future risk of exacerbations in Japanese patients with adult asthma: A prospective 1-year follow up study.
    Tanaka A; Uno T; Sato H; Jinno M; Hirai K; Miyata Y; Yamaguchi M; Ohta S; Homma T; Yamamoto M; Suzuki S; Yokoe T; Sagara H
    Allergol Int; 2017 Oct; 66(4):568-573. PubMed ID: 28318883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up.
    Kimura H; Konno S; Makita H; Taniguchi N; Shimizu K; Suzuki M; Kimura H; Goudarzi H; Nakamaru Y; Ono J; Ohta S; Izuhara K; Ito YM; Wenzel SE; Nishimura M;
    Clin Exp Allergy; 2018 Sep; 48(9):1137-1146. PubMed ID: 29781543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term future risk of severe exacerbations: Distinct 5-year trajectories of problematic asthma.
    Yii ACA; Tan JHY; Lapperre TS; Chan AKW; Low SY; Ong TH; Tan KL; Chotirmall SH; Sterk PJ; Koh MS
    Allergy; 2017 Sep; 72(9):1398-1405. PubMed ID: 28295424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of future exacerbation risk in patients with asthma.
    Papaioannou AI; Kostikas K; Bakakos P; Papaporfyriou A; Konstantellou E; Hillas G; Papatheodorou G; Koulouris NG; Papiris S; Loukides S
    Postgrad Med; 2016 Sep; 128(7):687-92. PubMed ID: 27494758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Biomarkers and Prediction of Future Exacerbations and Lung Function Decline in Adult Asthma.
    Semprini R; Williams M; Semprini A; McDouall A; Fingleton J; Holweg C; Weatherall M; Beasley R; Braithwaite I
    J Allergy Clin Immunol Pract; 2018; 6(6):1982-1988.e1. PubMed ID: 29609049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strategy for predicting future exacerbation of asthma using a combination of the Asthma Control Test and lung function test.
    Sato R; Tomita K; Sano H; Ichihashi H; Yamagata S; Sano A; Yamagata T; Miyara T; Iwanaga T; Muraki M; Tohda Y
    J Asthma; 2009 Sep; 46(7):677-82. PubMed ID: 19728204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.
    Bateman ED; Buhl R; O'Byrne PM; Humbert M; Reddel HK; Sears MR; Jenkins C; Harrison TW; Quirce S; Peterson S; Eriksson G
    J Allergy Clin Immunol; 2015 Jun; 135(6):1457-64.e4. PubMed ID: 25258144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of asthma exacerbations in children: results of a one-year prospective study.
    Robroeks CM; van Vliet D; Jöbsis Q; Braekers R; Rijkers GT; Wodzig WK; Bast A; Zimmermann LJ; Dompeling E
    Clin Exp Allergy; 2012 May; 42(5):792-8. PubMed ID: 22515395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of Irreversible Airflow Limitation in Asthma: Correlation with Severe Exacerbations.
    Matsunaga K; Hirano T; Oka A; Tanaka A; Kanai K; Kikuchi T; Hayata A; Akamatsu H; Akamatsu K; Koh Y; Nakanishi M; Minakata Y; Yamamoto N
    J Allergy Clin Immunol Pract; 2015; 3(5):759-64.e1. PubMed ID: 26054551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations.
    Ko FW; Hui DS; Leung TF; Chu HY; Wong GW; Tung AH; Ngai JC; Ng SS; Lai CK
    Respirology; 2012 Feb; 17(2):370-8. PubMed ID: 22107482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.
    Gelb AF; Flynn Taylor C; Shinar CM; Gutierrez C; Zamel N
    Chest; 2006 Jun; 129(6):1492-9. PubMed ID: 16778266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled nitric oxide as a predictor of exacerbation in children with moderate-to-severe asthma: a prospective, 5-month study.
    Cabral AL; Vollmer WM; Barbirotto RM; Martins MA
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):206-11. PubMed ID: 19788017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily exhaled nitric oxide measurements and asthma exacerbations in children.
    van der Valk RJ; Baraldi E; Stern G; Frey U; de Jongste JC
    Allergy; 2012 Feb; 67(2):265-71. PubMed ID: 21999328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with irreversible airway obstruction in nonsmoking adult patients with severe asthma.
    Ciebiada M; Domagała M; Gorska-Ciebiada M; Gorski P
    Allergy Asthma Proc; 2014; 35(5):72-9. PubMed ID: 25295799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
    Zeiger RS; Yegin A; Simons FE; Haselkorn T; Rasouliyan L; Szefler SJ; Chipps BE;
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):81-7. PubMed ID: 22289725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
    Baines KJ; Fu JJ; McDonald VM; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In moderate-to-severe asthma patients monitoring exhaled nitric oxide during exacerbation is not a good predictor of spirometric response to oral corticosteroid.
    Gelb AF; Moridzadeh R; Singh DH; Fraser C; George SC
    J Allergy Clin Immunol; 2012 Jun; 129(6):1491-8. PubMed ID: 22560478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of severe asthma and influences of early risk factors: a population-based cohort study.
    Chen W; Marra CA; Lynd LD; FitzGerald JM; Zafari Z; Sadatsafavi M
    Thorax; 2016 Mar; 71(3):267-75. PubMed ID: 26732738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study.
    Kirenga BJ; de Jong C; Mugenyi L; Katagira W; Muhofa A; Kamya MR; Boezen HM; van der Molen T
    Thorax; 2018 Oct; 73(10):983-985. PubMed ID: 29752346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.
    Jeong SH; Lee H; Carriere KC; Shin SH; Moon SM; Jeong BH; Koh WJ; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1857-65. PubMed ID: 27536097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.